Related Experiment Video

Updated: Aug 6, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.4K

The Prognostic Value of Cardiovascular Risk Factors and Laboratory Biomarkers in Predicting 6-Month Outcomes in

Alla Lubovich1, Mariana Issawy2, Liza Grosman-Rimon1

  • 1Department of Cardiovascular Medicine, Tzafon Medical Center, Lower Galilee, Israel, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

The Israel Medical Association Journal : IMAJ
|March 22, 2023
PubMed

Insights

Logarithm of brain natriuretic peptide (LogₑBNP) predicts major adverse cardiac and cerebrovascular events (MACCE) in non-ST-elevation myocardial infarction (NSTEMI) patients. Routine BNP evaluation is recommended for NSTEMI patients to assess prognosis.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Prognosis

Background:

  • Acute coronary syndrome (ACS) encompasses unstable angina, NSTEMI, and STEMI.
  • Existing prognostic scores like GRACE have limitations in certain populations and outcomes.
  • There is a need for improved prediction of clinical events beyond mortality in NSTEMI patients.

Purpose of the Study:

  • To evaluate traditional risk factors and laboratory biomarkers for predicting 6-month MACCE in NSTEMI patients treated with PCI.
  • To identify independent predictors of MACCE in this patient cohort.

Main Methods:

  • Retrospective study of 223 NSTEMI patients treated with PCI.
  • Data collected from April 2015 to August 2018.
  • Analysis included traditional risk factors and laboratory biomarkers.

Main Results:

  • Logarithm of brain natriuretic peptide (LogₑBNP), prior myocardial infarction (MI), and hemoglobin (Hb) levels predicted MACCE.
  • LogₑBNP was identified as an independent predictor of MACCE via multivariate logistic regression.

Conclusions:

  • LogₑBNP is a significant independent predictor of adverse prognosis in NSTEMI patients.
  • Routine assessment of BNP levels is recommended for NSTEMI patients to guide management and prognosis.
Abstract

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.5K
Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.2K

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
214
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
133
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
16
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
51
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
16